Paul Romness
Founder at OS Therapies, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert Bradway | M | 61 | 18 years | |
Alan Musso | M | 62 |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 1 years |
Esteban Santos | M | 56 | 17 years | |
Colin Goddard | M | 64 |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 4 years |
Joacim Borg | M | 32 |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 2 years |
Robert G. Petit | M | 64 |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 5 years |
Theodore F. Search | M | 42 |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 4 years |
John Ciccio | M | 43 |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | 4 years |
Jack Doll | M | - |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Pamela Wapnick | F | 58 | 9 years | |
Paul Eisenberg | M | - | 14 years | |
Dennis Fenton | M | 72 | 27 years | |
Gregory L. Tewalt | M | - | - | |
John Moriarty | M | 56 | 6 years | |
William P. Sheridan | M | 69 | 5 years | |
Joseph Newell | M | 54 | 7 years | |
Cynthia Flowers | F | 64 | 5 years | |
Anders Bylock | M | 70 |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | 5 years |
Jin Long Chen | M | 61 | 4 years | |
Andreas Grauer | M | 63 | - | |
Engelbert Willink | M | 64 |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | - |
William Ashton | M | 73 | 16 years | |
Nathan Hardy | M | 48 | 10 years | |
Vasant Prakash Gandhi | M | - | 5 years | |
Timothy Martin | M | 55 | 3 years | |
Wolfgang Baiker | M | - |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | 3 years |
Vance D. Coffman | M | 79 | 9 years | |
David Chang | M | 64 | 8 years | |
Winston Kung | M | 48 | 3 years | |
Joseph Leveque | M | 63 | 2 years | |
Timothy Powers | M | 58 | 5 years | |
James G. Stout | M | 58 | 4 years | |
Lorraine A. Fitzpatrick | M | 69 | 2 years | |
Michael Wittekind | M | 69 | 4 years | |
Jeffrey Wiezorek | M | 52 | 8 years | |
David B. Huang | M | 49 |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | 3 years |
Robert Steven Sikorski | M | - | 4 years | |
Marlene Haffner | M | 83 | 2 years | |
Daljit Singh Aurora | M | 55 | 7 years | |
Grégory Behar | M | 55 |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | 1 years |
Wen Chen Yeh | M | 61 | 10 years | |
James Scott Whitehurst | M | 58 | 8 years | |
George G Nomikos | M | - | 1 years | |
Jeff Miller | M | - |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | 4 years |
Margrit Schwarz | M | 60 | 7 years | |
Christophe Quéva | M | 57 | 5 years | |
Sesha Neervannan | M | 56 | 8 years | |
Roland Wandeler | M | 51 | - | |
David Weinreich | M | - | 7 years | |
Kenneth Lock | M | 50 | 6 years | |
Jörn Drappa | M | 60 | 3 years | |
David Green | M | - | 11 years | |
Eliot Charles | M | 62 | 3 years | |
Stephen Doyle | M | 50 |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | 4 years |
Ann Miller | M | 66 | 5 years | |
David Essayan | M | - | 4 years | |
Christopher Nardecchia | M | 62 | 11 years | |
Richard Peters | M | 61 | 3 years | |
Catherine Lee Kelleher | M | - | 7 years | |
Richard Sachse | M | - |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | - |
Beth Seidenberg | M | 67 | 3 years | |
Antonis Koutsoukos | M | - | 5 years | |
David Parkinson | M | 73 | 3 years | |
Juan Jaen | M | 66 | 10 years | |
Linda C. Heller | F | 60 | 4 years | |
Lisa Guttman | F | - | 7 years | |
Xiao Dong Yang | M | 64 | - | |
Lisa A. Evrén | F | - | 5 years | |
Ana G. Rodriguez | F | 56 | 2 years | |
Pirow Bekker | M | 63 | 8 years | |
Lauro A. González Moreno | M | 62 | - | |
Randal A. Hassler | M | 66 | 12 years | |
Steven J. Ruhl | M | - | - | |
Matthew Moyle | M | 63 |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | 5 years |
Richard Nanula | M | 63 | 6 years | |
Stephen Blackwood | M | 61 | 7 years | |
Richard Benton Phillips | M | 70 | 2 years | |
Doug Farrar | M | 59 | 7 years | |
John F. Weidenbruch | M | 63 | 10 years | |
Warren Wayne Myers | M | 62 | 10 years | |
H. Christian Fibiger | M | 80 | 4 years | |
Patrick Charles Frankham | M | 53 |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | - |
Vimal Srivastava | M | 58 | 3 years | |
Steven J. Roy | M | - | 13 years | |
Scott M. Wasserman | M | - | 14 years | |
Allan Hillgrove | M | 63 |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | 5 years |
Jesse Seton McGreivy | M | 54 | 6 years | |
Birgitte Volck | M | 61 | 5 years | |
Majed Kheir | M | 46 | 6 years | |
Keith Murphy | M | 52 | 10 years | |
MarySusan Howard | F | - | 5 years | |
Kevin L. Stark | M | - | 15 years | |
Marisa Co | F | - | 10 years | |
Richard Paulson | M | 56 | 10 years | |
Wolfgang Renz | M | 54 |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | - |
Grove Matsuoka | M | - | 12 years | |
Fanesca Young | M | - | 2 years | |
Kent Stemper | M | - | 2 years | |
Giuseppe Giorgini | M | - | - | |
Urte Gayko | M | 53 | 9 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 88 | 88.00% |
Germany | 12 | 12.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Paul Romness
- Personal Network